Dimitry S Davydow1, Erika D Lease2, Jorge D Reyes3. 1. Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA. Electronic address: ddavydo1@u.washington.edu. 2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington, Seattle, WA, USA. 3. Division of Transplant Surgery, Department of Surgery, University of Washington, Seattle, WA, USA.
Abstract
OBJECTIVE: To summarize and critically review the existing literature on the prevalence of posttraumatic stress disorder (PTSD) following organ transplantation, risk factors for posttransplantation PTSD and the relationship of posttransplant PTSD to other clinical outcomes including health-related quality of life (HRQOL) and mortality. METHODS: We conducted a systematic literature review using PubMed, CINAHL Plus, the Cochrane Library and PsycInfo and a search of the online contents of 18 journals. RESULTS: Twenty-three studies were included. Posttransplant, the point prevalence of clinician-ascertained PTSD ranged from 1% to 16% (n=738), the point prevalence of questionnaire-assessed substantial PTSD symptoms ranged from 0% to 46% (n=1024) and the cumulative incidence of clinician-ascertained transplant-specific PTSD ranged from 10% to 17% (n=482). Consistent predictors of posttransplant PTSD included history of psychiatric illness prior to transplantation and poor social support posttransplantation. Posttransplant PTSD was consistently associated with worse mental HRQOL and potentially associated with worse physical HRQOL. CONCLUSIONS: PTSD may impact a substantial proportion of organ transplant recipients. Future studies should focus on transplant-specific PTSD and clarify potential risk factors for, and adverse outcomes related to, posttransplant PTSD.
OBJECTIVE: To summarize and critically review the existing literature on the prevalence of posttraumatic stress disorder (PTSD) following organ transplantation, risk factors for posttransplantation PTSD and the relationship of posttransplant PTSD to other clinical outcomes including health-related quality of life (HRQOL) and mortality. METHODS: We conducted a systematic literature review using PubMed, CINAHL Plus, the Cochrane Library and PsycInfo and a search of the online contents of 18 journals. RESULTS: Twenty-three studies were included. Posttransplant, the point prevalence of clinician-ascertained PTSD ranged from 1% to 16% (n=738), the point prevalence of questionnaire-assessed substantial PTSD symptoms ranged from 0% to 46% (n=1024) and the cumulative incidence of clinician-ascertained transplant-specific PTSD ranged from 10% to 17% (n=482). Consistent predictors of posttransplant PTSD included history of psychiatric illness prior to transplantation and poor social support posttransplantation. Posttransplant PTSD was consistently associated with worse mental HRQOL and potentially associated with worse physical HRQOL. CONCLUSIONS:PTSD may impact a substantial proportion of organ transplant recipients. Future studies should focus on transplant-specific PTSD and clarify potential risk factors for, and adverse outcomes related to, posttransplant PTSD.
Authors: M A Dew; L H Roth; H C Schulberg; R G Simmons; R L Kormos; P T Trzepacz; B P Griffith Journal: Gen Hosp Psychiatry Date: 1996-11 Impact factor: 3.238
Authors: O J Bienvenu; J Gellar; B M Althouse; E Colantuoni; T Sricharoenchai; P A Mendez-Tellez; C Shanholtz; C R Dennison; P J Pronovost; D M Needham Journal: Psychol Med Date: 2013-02-26 Impact factor: 7.723
Authors: Mary Amanda Dew; Andrea F DiMartini; Annette J DeVito Dabbs; Kristen R Fox; Larissa Myaskovsky; Donna M Posluszny; Galen E Switzer; Rachelle A Zomak; Robert L Kormos; Yoshiya Toyoda Journal: Gen Hosp Psychiatry Date: 2012-01-14 Impact factor: 3.238
Authors: M S Guimaro; S S Lacerda; M R Aguilar; C H Karam; A M Kernkraut; B H Ferraz-Neto Journal: Transplant Proc Date: 2011 Jan-Feb Impact factor: 1.066
Authors: M A Dew; R L Kormos; S Winowich; R C Harris; E A Stanford; L Carozza; B P Griffith Journal: J Heart Lung Transplant Date: 2001-11 Impact factor: 10.247
Authors: R H Pietrzak; A Feder; R Singh; C B Schechter; E J Bromet; C L Katz; D B Reissman; F Ozbay; V Sharma; M Crane; D Harrison; R Herbert; S M Levin; B J Luft; J M Moline; J M Stellman; I G Udasin; P J Landrigan; S M Southwick Journal: Psychol Med Date: 2013-04-03 Impact factor: 7.723
Authors: Donald Edmondson; Safiya Richardson; Louise Falzon; Karina W Davidson; Mary Alice Mills; Yuval Neria Journal: PLoS One Date: 2012-06-20 Impact factor: 3.240
Authors: Katrin Birkefeld; Maximilian Bauer-Hohmann; Felix Klewitz; Eva-Marie Kyaw Tha Tun; Uwe Tegtbur; Lars Pape; Lena Schiffer; Mario Schiffer; Martina de Zwaan; Mariel Nöhre Journal: J Clin Psychol Med Settings Date: 2022-02-23
Authors: Rebekah P Nash; Marci M Loiselle; Jessica L Stahl; Jamie L Conklin; Terra L Rose; Alissa Hutto; Donna M Evon; Jennifer E Flythe; Eileen J Burker Journal: Kidney360 Date: 2022-08-01
Authors: Clare McKeaveney; Helen Noble; Aisling E Courtney; Sian Griffin; Paul Gill; William Johnston; Alexander P Maxwell; Francesca Teasdale; Joanne Reid Journal: Healthcare (Basel) Date: 2022-06-23